Placeholder text

Go to cart

Epilepsy: Genetics, Biomarkers, and advances toward Precision Medicine

By Mona El-Banna

Epilepsy: Genetics, Biomarkers, and advances toward Precision Medicine Natural Sciences

Epilepsy: Genetics, Biomarkers, and advances toward Precision Medicine

0 - Default Title
Description
Epilepsy is a heterogeneous neurological disorder characterized by recurrent, unprovoked seizures, with nearly one-third of patients remaining resistant to current therapies. Its multifactorial basis involves genetic, molecular, epigenetic, inflammatory, and metabolic contributors that drive disease heterogeneity. Genetic modifiers such as ion channel mutations (SCN1A, GABRA1, CHRNA4) and mTOR pathway disruptions (TSC1, DEPDC5), along with epigenetic mechanisms linking environmental influences to gene expression, play central roles in seizure susceptibility and treatment response. A broad spectrum of biomarkers-genetic, proteomic, metabolomic, imaging, and electrophysiological-provides critical insights for diagnosis, prognosis, and therapeutic strategies. Integrating molecular discoveries with clinical perspectives underscores the potential of biomarker-driven precision medicine, supporting targeted therapies, optimized patient stratification, and improved long-term outcomes in epilepsy.
Product details
Binding:
Paperback
Number of Pages:
88
Release Date:
2025-11-07
Publication Date:
2025-11-07
Publisher:
LAP LAMBERT Academic Publishing
Languages:
Original: English
ISBN10:
6209132251
ISBN13:
9786209132254
Weight:
149 g
Height:
150 cm
Width:
220 cm
Thickness:
6 cm
Buy on Amazon
Currently sold out